Azithromycin Dosing for 32-pound (14.5 kg) 3½-Year-Old Child
For this child, administer azithromycin 10 mg/kg (approximately 145 mg or 7.5 mL of 100 mg/5 mL suspension) on day 1, followed by 5 mg/kg (approximately 72.5 mg or 3.75 mL) once daily on days 2 through 5.
Standard Dosing Regimen
The FDA-approved dosing for pediatric community-acquired pneumonia and most respiratory infections follows a 5-day course 1:
- Day 1: 10 mg/kg as a single dose
- Days 2-5: 5 mg/kg once daily
For a 32-pound (14.5 kg) child, this translates to:
- Day 1: 145 mg (approximately 7.5 mL of 100 mg/5 mL suspension)
- Days 2-5: 72.5 mg (approximately 3.75 mL of 100 mg/5 mL suspension)
This dosing is supported by the Pediatric Infectious Diseases Society/Infectious Diseases Society of America guidelines for community-acquired pneumonia, which recommend azithromycin at 10 mg/kg on day 1, followed by 5 mg/kg/day once daily on days 2-5 for atypical pathogens including Mycoplasma pneumoniae and Chlamydophila pneumoniae 2.
Alternative Dosing Regimens (Indication-Specific)
For Acute Otitis Media
Three FDA-approved options exist 1:
- 5-day regimen: Same as above (10 mg/kg day 1, then 5 mg/kg days 2-5)
- 3-day regimen: 10 mg/kg once daily for 3 days (145 mg daily)
- Single-dose regimen: 30 mg/kg as a single dose (435 mg or approximately 22 mL)
For Acute Bacterial Sinusitis
- 3-day regimen: 10 mg/kg once daily for 3 days (145 mg daily) 1
For Pharyngitis/Tonsillitis
- 5-day regimen: 12 mg/kg once daily for 5 days (approximately 174 mg or 8.75 mL daily) 1
Important Clinical Considerations
Administration: Azithromycin suspension can be taken with or without food 1. The suspension is generally well-tolerated with good palatability in children 3, 4.
Common Pitfalls:
- Do not exceed adult maximum doses regardless of weight-based calculations
- The 30 mg/kg single-dose regimen for otitis media has higher rates of gastrointestinal adverse effects (though still generally mild) 3
- If the child vomits within 30 minutes of a 30 mg/kg dose, re-dosing at the same total dose has been studied in clinical trials 1
Safety Profile: Treatment-related adverse events occur in approximately 9% of pediatric patients, predominantly mild-to-moderate gastrointestinal complaints (5.3%) that rarely necessitate treatment discontinuation (1.3%) 4. The standard 5-day regimen is better tolerated than higher-dose alternatives 3.
Dosing Accuracy: For this specific weight (14.5 kg), the calculated doses fall between standard volume measurements. Rounding to the nearest practical volume (7.5 mL for day 1,3.75 mL for days 2-5) provides dosing within acceptable therapeutic ranges while maintaining simplicity 1.